United Kingdom· GB-APID-41278311000001104
Sodium iodide [I-131] 5.439GBq capsules T
A medicinal product containing sodium iodide [i-131], registered in United Kingdom by Curium Pharma UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sodium iodide [I-131]
- Manufacturer
- Curium Pharma UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium iodide [i-131] in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIODOPOLNarodowe Centrum Badań Jadrowych, Otwock
- FinlandI-131-C-BCIS bio international
- BelgiumCapsion 50 MBq - 3700 MBqCis Bio International
- GermanyIodopolNarodowe Centrum Badań Jądrowych
- SwedenNatriumjodid (I-131) Curiumpharma 37-7400 MBq Kapsel, hårdCurium Netherlands B.V.
- United StatesHICONJubilant DraxImage Inc., dba Jubilant Radiopharma
- SwitzerlandSodium iodide (I-131) capsule T Curium, Therapiekapselnb.e.imaging.ag
- IrelandSodium Iodide (I131) Capsule T 37-7400 MBq hard capsuleCurium Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Iodopol, Natriumjodid (131i) Curium
- Belgium · Sodium Iodide (I-131) Curium
- Bulgaria · Йодопол, Монийот-131
- Cyprus · Iodopol
- Czechia · Iodopol, Sodium Iodide (131i) Izotop
- Germany · Iodopol, Moniyot-131
- Denmark · Moniyot-131, Sodium Iodide (I-131) Polatom
- Estonia · Iodopol
- Spain · Ioduro (131i) De Sodio Curium Pharma Spain
- Finland · Sodium Iodide (I-131) Curium Netherlands, Sodium Iodide (I-131) För Terapeutisk Användning Curium Netherlands
- France · Iodure (131i) De Sodium Pour Therapie Curiumpharma
- Greece · Iodopol, Moniyot-131
- Hungary · 131i-Nátrium-Jodid Izotóp Intézet, Nátrium-Jodid [131i] Curium Netherlands B.V.
- Ireland · Sodium Iodide (I131) T Curium Netherlands
- Italy · Sodio Ioduro (131i) Polatom, Sodio Ioduro (I131) Curium Netherlands
- Lithuania · Sodium Iodide (131i) Polatom
- Luxembourg · Sodium Iodide (I-131) Capsule T Curium
- Netherlands · Sodium Iodide (I131) Capsules T Curium Netherlands
- Norway · Iodopol, Sodium Iodide (I131) T Curium Netherlands B.V.
- Poland · Iodopol, Iodopol Diagnostic
- Portugal · Iodeto De Sódio [i 131] T Curium Netherlands, Iodopol
- Romania · Fid-Na, Moniyot-131
- Sweden · Natriumjodid (I-131) Curiumpharma, Sodium Iodide (I-131) Polatom
- Slovenia · Natrii Iodidum (131i) Polatom
- Slovakia · Iodopol, Thyrotop
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da598aae-54f1-4e3c-b1b8-b1685f53eb56 GET /v1/drugs/da598aae-54f1-4e3c-b1b8-b1685f53eb56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41278311000001104",
"desc": "Sodium iodide [I-131] 5.439GBq capsules T (Curium Pharma UK Ltd)",
"form": "Oral capsule",
"vpid": "41288211000001104",
"source": "dmd",
"vtm_id": "783855009",
"strength": "5.439 GBq",
"substance": "Sodium iodide [I-131]",
"ingredient": "Sodium iodide [I-131]",
"supplier_code": "39344211000001103"
}See everything about sodium iodide [i-131].
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.